Xiaojing Li

Research progress of PD-1/PD-L1 immunotherapy in gastrointestinal tumors.

M. Mamun, Yichao Zheng, Jiangang Sun, 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Synthesis and discovery of 18β-glycyrrhetinic acid derivatives inhibiting cancer stem cell properties in ovarian cancer cells

A.-X. Li, Shaoda Ren, Xiaojing Li, 2019, RSC advances.

Synthesis and biological evaluation of celastrol derivatives as anti-ovarian cancer stem cell agents.

Ning-Li Li, Shaoda Ren, Wenxia Liu, 2019, European journal of medicinal chemistry.

From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer

Jiangang Sun, Xiaojing Li, Peng Chen, 2022, Journal of inflammation research.

Neospora caninum inhibits tumor development by activating the immune response and destroying tumor cells in a B16F10 melanoma model

Lei He, Wenchao Yan, M. Zhang, 2022, Parasites & Vectors.

Discovery of semisynthetic celastrol derivatives exhibiting potent anti-ovarian cancer stem cell activity and STAT3 inhibition.

C. Li, Shaoda Ren, Zhenzhen Gao, 2022, Chemico-biological interactions.

Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells

Shaoda Ren, Jie Ding, Xiaojing Li, 2019, European journal of pharmacology.